Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Aterian Inc (ATER) vs Charles Schwab Corporation Common Stock (SCHW) Price & Performance

Aterian IncTrade
Charles Schwab Corporation Common StockTrade

Price performance (Past 24H)

Key statistics

Aterian Inc vs Charles Schwab Corporation Common Stock — how do they compare? Aterian Inc trades at $1.17 (market cap $12.98M), while Charles Schwab Corporation Common Stock trades at $101.63 (market cap $175.83B). The key difference: Charles Schwab Corporation Common Stock is far larger — about 13546.2× Aterian Inc's market cap, and Charles Schwab Corporation Common Stock pays a 1.27% dividend while Aterian Inc pays none. Which is the better fit depends on your goals.

ATERSCHW
Market Cap
$12.98M$175.83B
Sector
Consumer CyclicalFinancials
52-Week High
$1.39$107.21
52-Week Low
$0.54$85.35
Enterprise Value
$13.56M
Dividend Yield
1.27%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Aterian Inc

Aterian (ATER) trades at $1.19, up 3.48% with a bullish technical signal despite negative profitability. Recent earnings beats and a pending asset sale that could return $0.85-$1.14 per share provide near-term catalysts. However, the company shows declining revenue from $221M in 2022 to $69M in 2025, with negative net income margins and cash flow challenges.

The outlook hinges on shareholder approval of the brand portfolio sale, offering potential shareholder returns near current price levels. Investment opportunity exists in the asset sale catalyst, but risks include ongoing operational losses, declining revenue, and negative cash flow. Analyst sentiment is evenly split between Buy and Hold recommendations.

Charles Schwab Corporation Common Stock

Charles Schwab (SCHW) trades at $102.38, down 0.72% on the day, with a bullish technical outlook and strong fundamentals. Recent earnings beats, including Q1 2026 EPS of $1.43 versus $1.40 expected, highlight robust profitability. The stock is supported by a 21.79% ROE and a net income margin of 37.99%, with revenue growth to $23.92 billion in 2025. Positive sentiment is fueled by a Zacks Strong Buy upgrade and a consensus price target of $122.71, suggesting 20% upside.

Outlook remains favorable given earnings momentum and retail trading growth, but risks include interest rate sensitivity and competitive pressures. Analyst consensus is 58% buy, with institutional confidence bolstered by a recent dividend payment. The stock's valuation at a P/E of 20.35 appears reasonable relative to growth, though high RSI levels indicate potential near-term consolidation.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Aterian Inc

Aterian Inc is a technology-enabled consumer products company. Its product categories include home and kitchen appliances, kitchenware, environmental appliances (dehumidifiers and air conditioners), beauty-related products, and consumer electronics. It has various owned and operated brands include Vremi, Healing Solutions, Xtava, TRUWEO, Spiralize, Pohl+Schmitt, and RIF6. The company generates revenue through the online sales of various consumer products that are sold online.

Read more on ATER

About Charles Schwab Corporation Common Stock

Charles Schwab operates in brokerage, banking, and asset-management businesses. The company runs a large network of brick-and-mortar brokerage branch offices, a well-established online investing website, and has mobile trading capabilities. It also operates a bank and a proprietary asset management business and offers services to independent investment advisors. The company is among the largest firms in the investment business, with over $8 trillion of client assets at the end of 2021. Nearly all of its revenue is from the United States.

Read more on SCHW